Revenue: As of FY2025 Q1, the actual value is USD 204 M.EPS: As of FY2025 Q1, the actual value is USD 3.32.EBIT: As of FY2025 Q1, the actual value is USD 55 M.<h3>Run-off Segment</h3><ul><li>Revenues: $14 million for the three months ended March 31, 2025.</li><li>Net Incurred Losses and LAE: - $26 million for the three months ended March 31, 2025.</li><li>Defendant Asbestos and Environmental Expenses: - $1 million for the three months ended March 31, 2025.</li><li>Salaries and Benefit Expenses: $28 million for the three months ended March 31, 2025.</li><li>Professional Fee Expenses: $6 million for the three months ended March 31, 2025.</li><li>Other Segment Expenses: $8 million for the three months ended March 31, 2025.</li><li>Segment Net Loss: - $1 million for the three months ended March 31, 2025.</li></ul><h3>Investments Segment</h3><ul><li>Revenues: $189 million for the three months ended March 31, 2025.</li><li>Income from Equity Method Investments: $4 million for the three months ended March 31, 2025.</li><li>Salaries and Benefit Expenses: $5 million for the three months ended March 31, 2025.</li><li>Professional Fee Expenses: $1 million for the three months ended March 31, 2025.</li><li>Other Segment Expenses: $4 million for the three months ended March 31, 2025.</li><li>Segment Net Income: $183 million for the three months ended March 31, 2025.</li></ul><h3>Corporate and Other</h3><ul><li>Other Income: $1 million for the three months ended March 31, 2025.</li><li>Net Incurred Losses and LAE: - $10 million for the three months ended March 31, 2025.</li><li>Defendant Asbestos and Environmental Expenses: - $5 million for the three months ended March 31, 2025.</li><li>Amortization of Net Deferred Charge Assets: - $30 million for the three months ended March 31, 2025.</li><li>General and Administrative Expenses: - $40 million for the three months ended March 31, 2025.</li><li>Interest Expense: - $23 million for the three months ended March 31, 2025.</li><li>Net Foreign Exchange Losses: - $16 million for the three months ended March 31, 2025.</li><li>Dividends on Preferred Shares: - $9 million for the three months ended March 31, 2025.</li><li>Total Corporate and Other Net Loss: - $132 million for the three months ended March 31, 2025.</li></ul><h3>Outlook</h3>The company anticipates receiving all requisite regulatory approvals for the merger by mid-2025, with the merger expected to close in mid-2025.

Enstar Group Pref Share ESGRO 7.0 Prep 03/01/24 E | 10-Q: FY2025 Q1 Revenue: USD 204 M